![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | C07D 277/20 | (2006.01) |
C07D 417/06 | (2006.01) | ||
A61K 31/426 | (2006.01) | ||
A61K 31/427 | (2006.01) | ||
A61P 37/06 | (2006.01) |
(11) | Number of the document | 1689726 |
(13) | Kind of document | T |
(96) | European patent application number | 04819591.1 |
Date of filing the European patent application | 2004-11-16 | |
(97) | Date of publication of the European application | 2006-08-16 |
(45) | Date of publication and mention of the grant of the patent | 2010-10-06 |
(46) | Date of publication of the claims translation | 2011-02-25 |
(86) | Number | PCT/EP2004/012953 |
Date | 2004-11-16 |
(87) | Number | WO 2005/054215 |
Date | 2005-06-16 |
(30) | Number | Date | Country code |
PCT/EP03/13072 | 2003-11-21 | WO |
(72) |
BOLLI, Martin, CH
SCHERZ, Michael, CH
MUELLER, Claus, DE
MATHYS, Boris, CH
BINKERT, Christoph, CH
NAYLER Oliver, CH
|
(73) |
Actelion Pharmaceuticals Ltd.,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 5-(benz-(Z)-iliden)-tiazolidin-4-ono dariniai, kaip imunosupresiniai agentai |
5-(BENZ- (Z) -YLIDENE) -THIAZOLIDIN-4-ONE DERIVATIVES AS IMMUNOSUPPRESSANT AGENTS |
Payment date | Validity (years) | Amount | |
2023-10-26 | 347.00 EUR |